SIDNEY; John

Patent Applications and Registrations

Patent applications and USPTO patent grants for SIDNEY; John.The latest application filed is for "toxoplasma gondii vaccines and their use".

Company Profile

5.17.48

SIDNEY; John - La Jolla US
Sidney; John - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Toxoplasma Gondii Vaccines And Their Use App 20200289629 - MCLEOD; Rima ; et al.	2020-09-17
Antigens and epitopes derived from Mycobacterium tuberculosis Grant 10,703,784 - Sette , et al.	2020-07-07
Toxoplasma Gondii Vaccines And Their Use App 20190282679 - MCLEOD; Rima ; et al.	2019-09-19
Peptide combinations and uses thereof in treating dust mite allergy Grant 10,059,751 - Lundegaard , et al. August 28, 2	2018-08-28
Peptide Combinations And Uses Thereof In Treating Dust Mite Allergy App 20160251403 - Lundegaard; Claus ; et al.	2016-09-01
Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid Compositions App 20160193316 - Sette; Alessandro ; et al.	2016-07-07
HLA binding motifs and peptides and their uses Grant 9,340,577 - Grey , et al. May 17, 2	2016-05-17
Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions Grant 9,266,930 - Sette , et al. February 23, 2	2016-02-23
Hla Class I A2 Tumor Associated Antigen Peptides And Vaccine Compositions App 20140147490 - Fikes; John D. ; et al.	2014-05-29
Antigens and Epitopes Derived From Mycobacterium Tuberculosis App 20140004151 - Sette; Alessandro ; et al.	2014-01-02
Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions App 20130017253 - SETTE; Alessandro ; et al.	2013-01-17
Plasmodium Falciparum Antigens And Methods Of Use App 20120015401 - Sette; Alessandro ; et al.	2012-01-19
Hla Class I A2 Tumor Associated Antigen Peptides And Vaccine Compositions App 20110318408 - Fikes; John D. ; et al.	2011-12-29
Plasmodium falciparum antigens and methods of use Grant 8,017,745 - Sette , et al. September 13, 2	2011-09-13
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions App 20110097352 - Sette; Alessandro ; et al.	2011-04-28
Peptides For Inducing A Ctl And/or Htl Response To Hepatitis C Virus App 20100099613 - Buyse; Marie-Ange ; et al.	2010-04-22
Inducing Cellular Immune Responses to Hepatitis B Virus Using Peptide and Nucleic Acid Compositions App 20100068228 - SETTE; Alessandro ; et al.	2010-03-18
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions App 20090311283 - Sette; Alessandro ; et al.	2009-12-17
Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions App 20090304746 - Sette; Alessandro ; et al.	2009-12-10
Inducing cellular immune responses to hepatitis B virus using peptide compositions Grant 7,611,713 - Sette , et al. November 3, 2	2009-11-03
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions App 20090214632 - Sette; Alessandro ; et al.	2009-08-27
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions Grant 7,572,882 - Sette , et al. August 11, 2	2009-08-11
HLA binding peptides and their uses App 20090012004 - Sette; Alessandro ; et al.	2009-01-08
HLA class I A2 tumor associated antigen peptides and vaccine compositions App 20080279924 - Fikes; John D. ; et al.	2008-11-13
HLA binding motifs and peptides and their uses App 20080260762 - Grey; Howard M. ; et al.	2008-10-23
HLA binding peptides and their uses Grant 7,252,829 - Sette , et al. August 7, 2	2007-08-07
HLA class I A2 tumor associated antigen peptides and vaccine compositions App 20070098776 - Fikes; John D. ; et al.	2007-05-03
Alteration of immune response using pan DR-binding peptides Grant 7,202,351 - Sette , et al. April 10, 2	2007-04-10
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions App 20070059799 - Sette; Alessandro ; et al.	2007-03-15
HLA binding motifs and peptides and their uses App 20070055049 - Grey; Howard M. ; et al.	2007-03-08
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions App 20070053922 - Sette; Alessandro ; et al.	2007-03-08
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions App 20070020327 - Fikes; John ; et al.	2007-01-25
Plasmodium falciparum antigens and methods of use App 20060165719 - Sette; Alessandro ; et al.	2006-07-27
Peptides for inducing a CTL and/or HTL response to hepatitis C virus App 20060093617 - Buyse; Marie-Ange ; et al.	2006-05-04
Hla binding peptides and their uses App 20060079453 - Sidney; John ; et al.	2006-04-13
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions Grant 7,026,443 - Sette , et al. April 11, 2	2006-04-11
Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions App 20050271676 - Sette, Alessandro ; et al.	2005-12-08
Inducing cellular immune responses to p53 using peptide and nucleic acid compositions App 20050196403 - Fikes, John ; et al.	2005-09-08
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions App 20050063983 - Sette, Alessandro ; et al.	2005-03-24
Induction of immune response against desired determinants App 20050049197 - Sette, Alessandro ; et al.	2005-03-03
CTL inducing peptides from c-erb2 (HER-2/neu) App 20040157780 - Grey, Howard M. ; et al.	2004-08-12
Subunit vaccines with a2 supermotifs App 20040157273 - Sidney, John ; et al.	2004-08-12
Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions App 20040146519 - Fikes, John ; et al.	2004-07-29
Subunit vaccines with A2 supermotifs App 20040096445 - Sidney, John ; et al.	2004-05-20
Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositions App 20040053822 - Fikes, John ; et al.	2004-03-18
Inducing cellular immune responses to p53 using peptide and nucleic acid compositions App 20040048790 - Fikes, John ; et al.	2004-03-11
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions App 20040037843 - Fikes, John ; et al.	2004-02-26
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions Grant 6,689,363 - Sette , et al. February 10, 2	2004-02-10
Hla class I a2 tumor associated antigen peptides and vaccine compositions App 20030224036 - Fikes, John D ; et al.	2003-12-04
HLA-A2.1 binding peptides and their uses App 20030185822 - Grey, Howard M. ; et al.	2003-10-02
Hla Binding Peptides And Their Uses App 20030152580 - SETTE, ALESSANDRO ; et al.	2003-08-14
HLA class I A2 tumor associated antigen peptides and vaccine compositions Grant 6,602,510 - Fikes , et al. August 5, 2	2003-08-05
Hla Binding Peptides And Their Uses App 20020177694 - SETTE, ALESSANDRO ; et al.	2002-11-28
Identification of broadly reactive DR restricted epitopes App 20020160019 - Sette, Alessandro ; et al.	2002-10-31
HLA binding peptides and their uses App 20020160960 - Sette, Alessandro ; et al.	2002-10-31
Hla Binding Peptides And Their Uses App 20020098197 - SETTE, ALESANDRO ; et al.	2002-07-25
Induction of immune response against desired determinants Grant 6,413,935 - Sette , et al. July 2, 2	2002-07-02
Identification of broadly reactive DR restricted epitopes Grant 6,413,517 - Sette , et al. July 2, 2	2002-07-02
Alteration of immune response using pan DR-binding peptides Grant 5,736,142 - Sette , et al. April 7, 1	1998-04-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.